MYC is commonly dysregulated in many high-grade B cell malignancies, including GC-derived lymphomas such as Burkitt lymphoma (BL) and diffuse large B cell lymphoma (DLBCL; ref. 7). This evidence concerns the gene MYC and Burkitt lymphoma.